Fungal cell gigantism during mammalian infection

PLoS Pathogens

Volumn 6, Issue 6, 2010, Pages

  Zaragoza, Oscar ^a,b   Rocío, García Rodas ^a   Nosanchuk, Joshua D ^b   Cuenca Estrella, Manuel ^a   Rodríguez Tudela, Juan Luis ^a   Casadevall, Arturo ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIC AMP; ORGANIC SOLVENT; FUNGAL DNA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL SIZE; CELL STRUCTURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DAUGHTER CELL; DNA CONTENT; FEMALE; FUNGAL CELL; GAMMA RADIATION; GIANT CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION; MAMMALIAN DISEASE; MORPHOLOGICAL ADAPTATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERIKARYON; PHENOTYPE; POLYPLOIDY; SIGNAL TRANSDUCTION; SURFACE PROPERTY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GIGANTISM; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG MYCOSIS; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHAGOSOME; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

FILOBASIDIELLA NEOFORMANS; FUNGI; MAMMALIA; MUS;

ANIMALS; CELL PROLIFERATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA RAYS; GIGANTISM; LUNG DISEASES, FUNGAL; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OXIDATIVE STRESS; PHAGOSOMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77954677531     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000945     Document Type: Article

References (68)

1. Casadevall A, Pirofski LA (2003) The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1: 17-24.
2. Whiteway M, Bachewich C (2007) Morphogenesis in Candida albicans. Annu Rev Microbiol 61: 529-553.
3. Sudbery P, Gow N, Berman J (2004) The distinct morphogenic states of Candida albicans. Trends Microbiol 12: 317-324.
4. Liu H (2001) Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 4: 728-735.
5. Maresca B, Kobayashi GS (1989) Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 53: 186-209.
6. Kane J (1984) Conversion of Blastomyces dermatitidis to the yeast form at 37 degrees C and 26 degrees C. J Clin Microbiol 20: 594-596.
7. Maresca B, Kobayashi GS (2000) Dimorphism in Histoplasma capsulatum and Blastomyces dermatitidis. Contrib Microbiol 5: 201-216.
8. Park BI, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
9. Casadevall A, Perfect JR (1998) Cryptococcus neoformans; Press A, ed. Washington DC: ASM Press.
10. Cherniak R (1988) Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol 2: 40-54.
11. Goldman DL, Lee SC, Casadevall A (1995) Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 63: 3448-3453.
12. Lee SC, Casadevall A, Dickson DW (1996) Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am J Pathol 148: 1267-1274.
13. Vecchiarelli A (2007) Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity. Crit Rev Immunol 27: 547-557.
14. Yauch LE, Lam JS, Levitz SM (2006) Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog 2: e120.
15. Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, et al. (2009) The Capsule of the Fungal Pathogen Cryptococcus neoformans. Adv Appl Microbiol 68: 133-216.
16. McClelland EE, Bernhardt P, Casadevall A (2006) Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun 74: 1500-1504.
17. Zaragoza O, Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6: 10-15.
18. Feldmesser M, Kress Y, Casadevall A (2001) Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147: 2355-2365.
19. Maxson ME, Cook E, Casadevall A, Zaragoza O (2007) The volume and hydration of the Cryptococcus neoformans polysaccharide capsule. Fungal Genet Biol 44: 180-186.
20. Zaragoza O, Taborda CP, Casadevall A (2003) The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Euro J Immnunol 33: 1957-1967.
21. Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, et al. (2008) Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol 10: 2043-2057.
22. Cruickshank JG, Cavill R, Jelbert M (1973) Cryptococcus neoformans of unusual morphology. Appl Microbiol 25: 309-312.
23. D'Souza CA, Alspaugh JA, Yue C, Harashima T, Cox GM, et al. (2001) Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 21: 3179-3191.
24. Love GL, Boyd GD, Greer DL (1985) Large Cryptococcus neoformans isolated from brain abscess. J Clin Microbiol 22: 1068-1070.
25. Zaragoza O, Mihu C, Casadevall A, Nosanchuk JD (2005) Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection. Antimicrob Agents Chemother 49: 4358-4361.
26. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A (1999) Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 19: 745-750.
27. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, et al. (2000) Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 68: 2845-2853.
28. Chaskes S, Frases S, Cammer M, Gerfen G, Casadevall A (2008) Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans. J Clin Microbiol 46: 255-264.
29. Bryan RA, Zaragoza O, Zhang T, Ortiz G, Casadevall A, et al. (2005) Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell 4: 465-475.
30. Dembitzer HM, Buza I, Reiss F (1972) Biological and electron microscopic changes in gamma radiated Cryptococcus neoformans. Mycopathol Mycol Appl 47: 307-315.
31. Gates MA, Thorkildson P, Kozel TR (2004) Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol 52: 13-24.
32. Zaragoza O, Casadevall A (2006) Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance. Cell Microbiol 8: 1862-1876.
33. Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A (2008) Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell 7: 602-609.
34. Zaragoza O, Telzak A, Bryan RA, Dadachova E, Casadevall A (2006) The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol Microbiol 59: 67-83.
35. Miyaji M, Nishimura K, Ajello L (1985) Scanning electron microscope studies on the parasitic cycle of Coccidioides immitis. Mycopathologia 89: 51-57.
36. de Hoog GS, Guarro J, Gené J, Figueras MJ (2000) Atlas of Clinical Fungi; de Hoog GS, Guarro J, Gené J, Figueras MJ, eds. Utrecht, Reus: Centraalbureau vor Schimmel Cultures, Universitat Rovira i Virgili.
37. Alspaugh JA, Pukkila-Worley R, Harashima T, Cavallo LM, Funnell D, et al. (2002) Adenylyl cyclase functions downstream of the Galpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot Cell 1: 75-84.
38. Alspaugh JA, Cavallo LM, Perfect JR, Heitman J (2000) RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol 36: 352-365.
39. Alvarez M, Casadevall A (2006) Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 16: 2161-2165.
40. Alvarez M, Casadevall A (2007) Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol 8: 16.
41. Ma H, Croudace JE, Lammas DA, May RC (2007) Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol 8: 15.
42. Ma H, Croudace JE, Lammas DA, May RC (2006) Expulsion of live pathogenic yeast by macrophages. Curr Biol 16: 2156-2160.
43. Luo Y, Alvarez M, Xia L, Casadevall A (2008) The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation. PLoS One 3: e3219.
44. Cleare W, Casadevall A (1999) Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med Mycol 37: 235-243.
45. Aldea M, Gari E, Colomina N (2007) Control of cell cycle and cell growth by molecular chaperones. Cell Cycle 6: 2599-2603.
46. Sugimoto-Shirasu K, Roberts K.(2003) ''Big it up'': endoreduplication and cell-size control in plants. Curr Opin Plant Biol 6: 544-553.
47. Grebien F, Dolznig H, Beug H, Mullner EW (2005) Cell size control: new evidence for a general mechanism. Cell Cycle 4: 418-421.
48. Cavalier-Smith T (1978) Nuclear volume control by nucleoskeletal DNA, selection for cell volume and cell growth rate, and the solution of the DNA C-value paradox. J Cell Sci 34: 247-278.
49. Kondorosi E, Roudier F, Gendreau E (2000) Plant cell-size control: growing by ploidy? Curr Opin Plant Biol 3: 488-492.
50. Mendell JE, Clements KD, Choat JH, Angert ER (2008) Extreme polyploidy in a large bacterium. Proc Natl Acad Sci U S A 105: 6730-6734.
51. Mergaert P, Uchiumi T, Alunni B, Evanno G, Cheron A, et al. (2006) Eukaryotic control on bacterial cell cycle and differentiation in the Rhizobium-legume symbiosis. Proc Natl Acad Sci U S A 103: 5230-5235.
52. Shea JM, Kechichian TB, Luberto C, Del Poeta M (2006) The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect Immun 74: 5977-5988.
53. Moyrand F, Fontaine T, Janbon G (2007) Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol 64: 771-781.
54. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, et al. (2009) Evidence For A Role Of Monocytes In Dissemination And Brain Invasion By Cryptococcus Neoformans. Infect Immun 77: 120-127.
55. Kechichian TB, Shea J, Del Poeta M (2007) Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Crypto-coccus neoformans in immunodeficient mice. Infect Immun 75: 4792-4798.
56. Shao X, Mednick A, Alvarez M, van Rooijen N, Casadevall A, et al. (2005) An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 175: 3244-3251.
57. Zaragoza O, Alvarez M, Telzak A, Rivera J, Casadevall A (2007) The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect Immun 75: 2729-2739.
58. Nosanchuk JD, Rosas AL, Lee SC, Casadevall A (2000) Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355: 2049-2050.
59. Bottone EJ, Horga M, Abrams J.(1999)''Giant'' blastoconidia of Candida albicans: morphologic presentation and concepts regarding their production. Diagn Microbiol Infect Dis 34: 27-32.
60. Alasio TM, Lento PA, Bottone EJ (2003) Giant blastoconidia of Candida albicans. A case report and review of the literature. Arch Pathol Lab Med 127: 868-871.
61. Perfect JR, Lang SDR, Durack DT (1980) Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101: 177-194.
62. Kwon-Chung KJ (1976) Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 68: 821-833.
63. Garcia-Rivera J, Eisenman HC, Nosanchuk JD, Aisen P, Zaragoza O, et al. (2005) Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates. Fungal Genet Biol 42: 989-998.
64. Feldmesser M, Kress Y, Novikoff P, Casadevall A (2000) Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68: 4225-4237.
65. Glatman-Freedman A, Martin JM, Riska PF, Bloom BR, Casadevall A (1996) Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol 34: 2795-2802.
66. Maxson ME, Dadachova E, Casadevall A, Zaragoza O (2007) Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell 6: 95-109.
67. Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, et al. (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42: 1437-1446.
68. Breiman L, Friedman JH, Olshen JH, Stone CG (1984) Classification and regression trees. Belmont: Wadsworth International.